Actual Medicinal Product (AMP) - Xeljanz 5mg tablets (Pfizer Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Xeljanz 5mg tablets | Start Date 06-04-2017 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| BNF | Start Date | End Date |
|---|---|---|
| Previous BNF 10010300 | Start Date 22-08-2017 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 34275911000001103 | 06-04-2017 |
Parent Products
-
VTMTofacitinib
-
VMPTofacitinib 5mg tablets
-
AMP(Current) Xeljanz 5mg tablets (Pfizer Ltd) (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 56 tablet | 69003 |